Recruiting
Phase 2
Breast Neoplasms
Eli Lilly and Company · started 2026-05-13
📍 Alabama · Arizona · California · Colorado · Florida · Georgia · Indiana · Kentucky
NCT07287098 on ClinicalTrials.gov ↗
Recruiting
Phase 3
Growth Hormone Deficiency (GHD)
Lumos Pharma · started 2026-05-20
📍 Alabama · California · Colorado · District of Columbia · Florida · Indiana · Iowa · Louisiana
NCT06948214 on ClinicalTrials.gov ↗
Active
Phase 3
Hidradenitis Suppurativa
Novartis Pharmaceuticals · started 2025-03-20
📍 Alabama · Arizona · California · Florida · Georgia · Illinois · Indiana · Massachusetts
NCT06840392 on ClinicalTrials.gov ↗
Recruiting
Phase 2
Macular Edema
Boehringer Ingelheim · started 2025-06-05
📍 Arizona · California · Colorado · Florida · Indiana · Kansas · Maryland · Nevada
NCT06962839 on ClinicalTrials.gov ↗
By invitation
Prader-Willi Syndrome
Soleno Therapeutics, Inc. · started 2025-11-26
📍 Arizona · California · Colorado · Georgia · Illinois · Indiana · Massachusetts · Michigan
NCT07450664 on ClinicalTrials.gov ↗
Recruiting
Phase 3
Crohn's Disease, Obesity or Overweight
Eli Lilly and Company · started 2025-06-26
📍 Alabama · California · Florida · Idaho · Illinois · Indiana · Kentucky · Louisiana
NCT06937099 on ClinicalTrials.gov ↗
Recruiting
Phase 3
Peripheral Arterial Disease
Eli Lilly and Company · started 2025-10-31
📍 Alabama · Arizona · California · Colorado · Florida · Indiana · Maryland · Michigan
NCT07223593 on ClinicalTrials.gov ↗
Recruiting
Phase 3
Episodic Migraine
AbbVie · started 2023-05-01
📍 Alabama · Arkansas · California · Colorado · Florida · Georgia · Indiana · Kansas
NCT05711394 on ClinicalTrials.gov ↗
Recruiting
Phase 2
Nausea, Vomiting, Drug-Related Side Effects and Adverse Reactions, Neoplasms
Eli Lilly and Company · started 2025-11-28
📍 California · Colorado · Florida · Georgia · Illinois · Indiana · Mississippi · New York
NCT07169851 on ClinicalTrials.gov ↗
Recruiting
Phase 3
Prostate Cancer
AstraZeneca · started 2025-08-06
📍 Arizona · California · Colorado · Florida · Georgia · Illinois · Indiana · Maryland
NCT06952803 on ClinicalTrials.gov ↗
Recruiting
Phase 1
Advanced Relapsed or Refractory Germ Cell Tumours, Advanced Relapsed or Refractory Endometrial Cancer, Advanced Relapsed or Refractory Ovarian Cancer
Boehringer Ingelheim · started 2026-02-27
📍 California · Indiana · Texas
NCT07306559 on ClinicalTrials.gov ↗
Recruiting
Phase 2
Opioid Use Disorder
Eli Lilly and Company · started 2026-02-13
📍 Arizona · Arkansas · California · Florida · Illinois · Indiana · Kentucky · Maryland
NCT07420283 on ClinicalTrials.gov ↗
Recruiting
Phase 3
Metabolic Dysfunction Associated Steatohepatitis (MASH), Liver Fibrosis
Boehringer Ingelheim · started 2024-10-14
📍 Alabama · Arizona · California · Colorado · Connecticut · Florida · Georgia · Indiana
NCT06632444 on ClinicalTrials.gov ↗
Recruiting
Phase 1
Prostate Cancer
Amgen · started 2020-03-04
📍 California · Colorado · Connecticut · Georgia · Indiana · Kansas · Louisiana · Missouri
NCT04221542 on ClinicalTrials.gov ↗
Recruiting
Phase 3
Heart Failure
Boehringer Ingelheim · started 2024-06-17
📍 Alabama · California · Connecticut · Florida · Georgia · Idaho · Illinois · Indiana
NCT06424288 on ClinicalTrials.gov ↗
Recruiting
Phase 3
Non-small Cell Lung Cancer
Merck Sharp & Dohme LLC · started 2025-10-08
📍 Alabama · Connecticut · Florida · Indiana · Maine · New York · Oregon · Pennsylvania
NCT07190248 on ClinicalTrials.gov ↗
Recruiting
Phase 1/Phase 2
Acne
Sanofi Pasteur, a Sanofi Company · started 2024-04-05
📍 Arizona · California · Florida · Georgia · Illinois · Indiana · Iowa · Kentucky
NCT06316297 on ClinicalTrials.gov ↗
Recruiting
Phase 3
Ovarian Neoplasms, Ovarian Cancer
Merck Sharp & Dohme LLC · started 2026-02-16
📍 Alabama · California · Florida · Georgia · Illinois · Indiana · Louisiana · Maine
NCT07318558 on ClinicalTrials.gov ↗
Recruiting
Phase 3
Non Small Cell Lung Cancer
Merck Sharp & Dohme LLC · started 2024-04-03
📍 Arkansas · California · Connecticut · Florida · Georgia · Illinois · Indiana · Kentucky
NCT06312137 on ClinicalTrials.gov ↗
Recruiting
Phase 2
Type 2 Diabetes
Eli Lilly and Company · started 2025-03-28
📍 Arizona · California · Florida · Georgia · Idaho · Indiana · New Jersey · New York
NCT06897475 on ClinicalTrials.gov ↗
Recruiting
Phase 3
Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Chronic Lymphocytic, Small-Cell Lymphoma, Lymphoma, Small Lymphocytic
Merck Sharp & Dohme LLC · started 2023-08-08
📍 Arkansas · California · Florida · Indiana · Maryland · Mississippi · Missouri · Montana
NCT05947851 on ClinicalTrials.gov ↗
Active
Phase 4
Diffuse Astrocytoma, Anaplastic Astrocytoma, Astrocytoma, Oligodendroglioma, Childhood
Novartis Pharmaceuticals · started 2019-11-04
📍 Arizona · District of Columbia · Florida · Indiana · Maryland · Massachusetts · Minnesota · New York
NCT03975829 on ClinicalTrials.gov ↗
Active
Phase 2
Moderate to Severe Atopic Dermatitis
Nektar Therapeutics · started 2023-11-15
📍 Arkansas · California · Florida · Georgia · Indiana · Kentucky · Michigan · Nevada
NCT06136741 on ClinicalTrials.gov ↗
Recruiting
Phase 3
Metabolic Dysfunction Associated Steatohepatitis
Boehringer Ingelheim · started 2024-11-12
📍 Arizona · California · Colorado · Connecticut · Florida · Georgia · Indiana · Iowa
NCT06632457 on ClinicalTrials.gov ↗
Recruiting
Phase 2
Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate, Ulcerative Colitis, Active Severe
Eli Lilly and Company · started 2026-03-26
📍 Arizona · California · Colorado · Connecticut · Florida · Idaho · Illinois · Indiana
NCT07415044 on ClinicalTrials.gov ↗
Active
Phase 3
HIV Infections
ViiV Healthcare · started 2015-02-23
📍 California · Colorado · Connecticut · District of Columbia · Florida · Georgia · Illinois · Indiana
NCT02362503 on ClinicalTrials.gov ↗
No trials match your search.